跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IN-11
首页
药物
IN-11
IN-11
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING
US 2024317847 A1
申请人: BAYER AG
优先权: 2021
CN
EP
US
WO
7 件公开
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
US 6964768 B2
申请人: BRIGHAM & WOMENS HOSPITAL
优先权: 2000
US
7 件公开
Cysteine muteins in the C-D loop of human interleukin-11
US 7495087 B2
申请人: BOLDER BIOTECHNOLOGY INC
优先权: 2006
US
7 件公开
Processes and novel intermediates for 11-oxa prostaglandin synthesis
US 2002002284 A1
申请人: DELGADO PETE
优先权: 2001
US
6 件公开
Genes participating in the synthesis of fatty acid having trans-11-,cis-13-conjugated double bond and utilization thereof
US 7402418 B2
申请人: PLANTECH RES INST
优先权: 2001
EP
US
WO
4 件公开
IL-11 muteins
US 7993637 B2
申请人: CSL LTD
优先权: 2008
US
4 件公开
USE OF ANTI-INTERLEUKIN-11 ANTIBODY IN PREPARATION OF DRUG FOR TREATING TUMORS
EP 4755910 A1
申请人: MABWELL SHANGHAI BIOSCIENCE CO LTD
优先权: 2023
CN
EP
WO
3 件公开
Therapeutic targeting of Cadherin 11 in cancer
US 12522657 B2
申请人: MASSACHUSETTS GEN HOSPITAL
优先权: 2021
US
WO
3 件公开
Application of MAGL inhibitor in preparation of antitumor drugs
CN 115518068 A
申请人: SHANGDONG NEW TIME PHARM PROD
优先权: 2021
CN
3 件公开
Combination Therapy
US 2008125447 A1
申请人: WEDGE STEPHEN ROBERT
优先权: 2004
CN
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈